The deal size was increased to $200M from $175M and priced below last closing price of $17.74. JPMorgan, TD Cowen and Guggenheim are acting as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EYPT:
- EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
- EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
- EyePoint announces $175M common stock offering
- EyePoint announces EYP-1901 achieved primary endpoints in Phase 2 trial
- EyePoint reports inducement grants under Nasdaq listing rule